ArticleBiomedicines2024

The Randomized, Multicenter, Open-Label, Controlled POLBOS 3 Trial Comparing Regular Drug-Eluting Stents and the Sirolimus-Eluting BiOSS LIM C Dedicated Coronary Bifurcation Stent: Four-Year Results.

Robert J Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.